Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Lowery MA"'
Publikováno v:
Cancer Journal; 2012 Nov, Vol. 18 Issue 6, p609-613, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lowery MA, O'reilly EM
Publikováno v:
Oncology (08909091); Dec2010, Vol. 24 Issue 14, p1339-1342, 4p
Publikováno v:
Journal of NeuroEngineering and Rehabilitation, Vol 1, Iss 1, p 2 (2004)
Abstract Background In investigations of the human motor system, two approaches are generally employed toward the identification of common modulating drives from motor unit recordings. One is a frequency domain method and uses the coherence function
Externí odkaz:
https://doaj.org/article/9d9dd373dcf14631b0e7a11dc0e6b31d
Autor:
Lowery MA; Trinity St James Cancer Institute, Dublin D08 W9RT, Ireland. Electronic address: mlowery@tcd.ie.
Publikováno v:
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Aug; Vol. 9 (8), pp. 679-681. Date of Electronic Publication: 2024 Jun 18.
Autor:
Power RF; School of Medicine, Trinity College Dublin, Dublin, Ireland.; Cancer Genetics service, Trinity St James's Cancer Institute, Dublin, Ireland., Doherty DE; Mater Misericordiae University Hospital, Eccles Street, Dublin, Ireland., Horgan R; Lynch syndrome Ireland, Dublin, Ireland., Fahey P; Lynch syndrome Ireland, Dublin, Ireland., Gallagher DJ; School of Medicine, Trinity College Dublin, Dublin, Ireland.; Cancer Genetics service, Trinity St James's Cancer Institute, Dublin, Ireland.; Department of Medical Oncology, Trinity St James's Cancer Institute, Dublin, Ireland., Lowery MA; School of Medicine, Trinity College Dublin, Dublin, Ireland.; Department of Medical Oncology, Trinity St James's Cancer Institute, Dublin, Ireland., Cadoo KA; School of Medicine, Trinity College Dublin, Dublin, Ireland. KCadoo@stjames.ie.; Cancer Genetics service, Trinity St James's Cancer Institute, Dublin, Ireland. KCadoo@stjames.ie.; Department of Medical Oncology, Trinity St James's Cancer Institute, Dublin, Ireland. KCadoo@stjames.ie.
Publikováno v:
Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2024 Jun 14; Vol. 22 (1), pp. 10. Date of Electronic Publication: 2024 Jun 14.
Autor:
Taskén K; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. kjetil.tasken@medisin.uio.no., F Haj Mohammad S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands. s.f.haj_mohammad@lumc.nl., Fagereng GL; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. gfageren@ous-hf.no., Sørum Falk R; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. rs@ous-hf.no., Helland Å; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. aslaug.helland@medisin.uio.no., Barjesteh van Waalwijk van Doorn-Khosrovani S; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands; CZ Health Insurance, Tilburg, The Netherlands. sahar.van.waalwijk@cz.nl., Steen Carlsson K; Swedish Institute for Health Economics, Lund, Sweden. katarina.steen_carlsson@ihe.se., Ryll B; Stockholm School of Economics Institute for Research, Stockholm, Sweden. Bettina.Ryll@hhs.se., Jalkanen K; Clinical Trial Unit, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland. katriina.jalkanen@hus.fi., Edsjö A; Department of Clinical Genetics, Pathology and Molecular Diagnostics, Region Skåne, Malmö, Sweden. anders.edsjo@skane.se., Russnes HG; Institute for Cancer Research, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Pathology, Oslo University Hospital, Oslo, Norway. h.e.g.russnes@medisin.uio.no., Lassen U; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. ulrik.lassen@regionh.dk., Hallersjö Hult E; Stockholm School of Economics Institute for Research, Stockholm, Sweden. ebba.hallersjo.hult@hhs.se., Lugowska I; Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland. Iwona.Lugowska@nio.gov.pl., Blay JY; Centre Léon Bérard, Lyon, France. jean-yves.blay@lyon.unicancer.fr., Verlingue L; Centre Léon Bérard, Lyon, France. Loic.VERLINGUE@lyon.unicancer.fr., Abel E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. edvard.abel@vgregion.se., Lowery MA; Trinity St James Cancer Institute, Trinity College, Dublin, Ireland. MLOWERY@tcd.ie., Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK. matthew.krebs@nhs.net., Staal Rohrberg K; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. kristoffer.staal.rohrberg@regionh.dk., Ojamaa K; Hematology-Oncology Clinic at Tartu University Hospital, Tartu, Estonia. Kristiina.Ojamaa@kliinikum.ee., Oliveira J; Instituto Português de Oncologia do Porto FG, Porto, Portugal. julio.oliveira@ipoporto.min-saude.pt., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. h.verheul@erasmusmc.nl., Voest EE; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. e.voest@nki.nl., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands. a.j.gelderblom@lumc.nl.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 May 23; Vol. 63, pp. 385-391. Date of Electronic Publication: 2024 May 23.
Autor:
Power RF; Mater Misericordiae University Hospital, Dublin, Ireland.; Cancer Genetics Service, Trinity St James's Cancer Institute, Dublin, Ireland., Doherty DE; School of Medicine, Trinity College Dublin, Dublin, Ireland., Parker I; Department of Biostatistics, Cancer Trials Ireland, Dublin, Ireland., Gallagher DJ; Cancer Genetics Service, Trinity St James's Cancer Institute, Dublin, Ireland.; School of Medicine, Trinity College Dublin, Dublin, Ireland.; Department of Medical Oncology, Trinity St James's Cancer Institute, Dublin, Ireland., Lowery MA; School of Medicine, Trinity College Dublin, Dublin, Ireland.; Department of Medical Oncology, Trinity St James's Cancer Institute, Dublin, Ireland., Cadoo KA; Cancer Genetics Service, Trinity St James's Cancer Institute, Dublin, Ireland.; School of Medicine, Trinity College Dublin, Dublin, Ireland.; Department of Medical Oncology, Trinity St James's Cancer Institute, Dublin, Ireland.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Jan; Vol. 8, pp. e2300196.
Autor:
Rha SY; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: rha7655@yuhs.ac., Oh DY; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea., Yañez P; Department of Internal Medicine, James Lind Cancer Research Center, Universidad de La Frontera, Temuco, Chile., Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Lee J; Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea., Rivera F; Department of Medical Oncology, University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain., Alves GV; Centro Integrado de Pesquisa em Oncologia, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil., Garrido M; Department of Hemato-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile., Shiu KK; Gastrointestinal Oncology Service, University College London Hospitals, University College London Cancer Institute, NHS Foundation Trust, London, UK., Fernández MG; Hemato Oncólogo, IMAT-Oncomedica, Montería, Colombia., Li J; Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China., Lowery MA; Department of Medical Oncology, Trinity St James Cancer Institute, Dublin, Ireland., Çil T; Department of Medical Oncology, Health and Science University, Adana City Hospital, Adana, Turkey., Cruz FM; Department of Medical Oncology, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil., Qin S; Department of Medical Oncology, Cancer Center of People's Liberation Army, Nanjing, China., Luo S; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China., Pan H; Department of Medical Oncology, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, China., Wainberg ZA; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Yin L; Biostatistics and Research Decision Sciences, Merck, Rahway, NJ, USA., Bordia S; Global Clinical Development, Merck, Rahway, NJ, USA., Bhagia P; Global Clinical Development, Merck, Rahway, NJ, USA., Wyrwicz LS; Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Nov; Vol. 24 (11), pp. 1181-1195. Date of Electronic Publication: 2023 Oct 21.
Autor:
Reynolds JV; Cancer Trials Ireland, Dublin, Ireland; St James's Hospital, Dublin, Ireland. Electronic address: reynoldsjv@stjames.ie., Preston SR; Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., O'Neill B; St Luke's Radiation Oncology Network, Dublin, Ireland., Lowery MA; St James's Hospital, Dublin, Ireland., Baeksgaard L; Rigshopitalet, Copenhagen, Denmark., Crosby T; Velindre University NHS Trust, Cardiff, UK., Cunningham M; St Luke's Radiation Oncology Network, Dublin, Ireland., Cuffe S; St James's Hospital, Dublin, Ireland., Griffiths GO; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Parker I; Cancer Trials Ireland, Dublin, Ireland., Risumlund SL; Rigshopitalet, Copenhagen, Denmark., Roy R; Hull University Teaching Hospitals NHS Trust, Hull, UK., Falk S; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Hanna GB; St Mary's Hospital, Imperial College, London, UK., Bartlett FR; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Alvarez-Iglesias A; HRB Clinical Research Facility, NUI Galway, Galway, Ireland., Achiam MP; Rigshopitalet, Copenhagen, Denmark., Nilsson M; Division of Surgery, CLINTEC, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Piessen G; Claude Huriez University Hospital, Lille, France., Ravi N; St James's Hospital, Dublin, Ireland., O'Toole D; St James's Hospital, Dublin, Ireland., Johnston C; St James's Hospital, Dublin, Ireland., McDermott RS; Cancer Trials Ireland, Dublin, Ireland., Turkington RC; Belfast Health and Social Care Trust, Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, UK., Wahed S; Northern Oesophago-Gastric Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Sothi S; University Hospitals Coventry and Warwickshire, Walsgrave, Coventry, UK., Ford H; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Wadley MS; Worcestershire Acute Hospitals NHS Trust, Worcestershire Oncology Centre, Worcestershire Royal Hospital, Worcester, UK., Power D; Cork University Hospital, Wilton, Cork, Ireland.
Publikováno v:
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2023 Nov; Vol. 8 (11), pp. 1015-1027. Date of Electronic Publication: 2023 Sep 18.